[EN] BIARYLETHER IMIDAZOPYRAZINE BTK INHIBITORS<br/>[FR] INHIBITEURS DE BTK À BASE DE BIARYLÉETHER D'IMIDAZOPYRAZINE
申请人:MERCK SHARP & DOHME
公开号:WO2016106652A1
公开(公告)日:2016-07-07
Provided are Bruton's Tyrosine Kinase (Btk) inhibitor compounds of Formula I, or pharmaceutically acceptable salts thereof, or pharmaceutical compositions comprising these compounds and their use in therapy. In particular, provided is the use of Btk inhibitor compounds of Formula I in the treatment of Btk mediated disorders.